A multicenter, randomized double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease

1987 ◽  
Vol 5 (5) ◽  
pp. 437
Author(s):  
Ian Cowan
Keyword(s):  
Duodenal Ulcer ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Duodenal Ulcer Disease ◽  
Ulcer Disease

A Multicenter, Randomized, Double-Blind Study Comparing Famotidine with Cimetidine in the Treatment of Active Duodenal Ulcer Disease

Digestion ◽  
1989 ◽  
Vol 42 (2) ◽  
pp. 86-92 ◽  
Author(s):  
L. Rodrigo ◽  
J. Viver ◽  
F. Conchillo ◽  
E. Barrio ◽  
M. Forné ◽  
...  
Keyword(s):  
Duodenal Ulcer ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Duodenal Ulcer Disease ◽  
Ulcer Disease

A Multicenter, Randomized, Double-Blind Study Comparing a Daily Bedtime Administration of Famotidine and Ranitidine in Short-Term Treatment of Active Duodenal Ulcer

Digestion ◽  
1989 ◽  
Vol 42 (2) ◽  
pp. 79-85 ◽  
Author(s):  
R. Alcalá-Santaella ◽  
J. Guardia ◽  
J. Pajares ◽  
J. Piqué ◽  
L. Pita ◽  
...  
Keyword(s):  
Duodenal Ulcer ◽  
Term Treatment ◽  
Blind Study ◽  
Double Blind Study ◽  
Short Term ◽  
Short Term Treatment ◽  
Double Blind

Cimetidine in the Treatment of Duodenal Ulcer: Double-Blind Study

1978 ◽  
Vol 6 (4) ◽  
pp. 351-354 ◽  
Author(s):  
J J Villalobos ◽  
J Elizondo ◽  
L Guevara ◽  
F Centeno
Keyword(s):  
Duodenal Ulcer ◽  
Clinical Observation ◽  
Blood Chemistry ◽  
Blind Study ◽  
Double Blind Study ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Placebo Tablet ◽  
Complete Blood Counts ◽  
Observation Period

To determine the efficacy and safety of cimetidine in the treatment of duodenal ulcer, forty-five patients with this diagnosis were selected for a double-blind study. Diagnosis was confirmed by endoscopy and photography of the lesion. Cimetidine in the form of 200 mg tablets was administered to twenty-four patients at the rate of 1 tablet t.i.d.p.c. and 2 tablets h.s. The same dosage of an identically appearing placebo tablet was given to twenty-one patients. The only other medication permitted was an aluminum + magnesium gel antacid p.r.n. Patients and medication were randomized, the same patients being seen by the same physician throughout the six-week observation period. Laboratory monitoring of patients (complete blood counts, blood chemistry, urinalysis, gastric acidity) took place at one, two, four and six weeks as did clinical observation. Three placebo patients withdrew from the study. The patients on cimetidine showed a statistically significant greater number of healed ulcers, early and late in the treatment; earlier and more persistent pain relief in a greater number; and considerably fewer requiring antacid than those patients on placebo. No side-effects were noted.

scholarly journals Acid perfusion of duodenal ulcer craters and ulcer pain: a controlled double blind study.

Gut ◽  
1986 ◽  
Vol 27 (8) ◽  
pp. 942-945 ◽  
Author(s):  
J Y Kang ◽  
I Yap ◽  
R Guan ◽  
H H Tay
Keyword(s):  
Duodenal Ulcer ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Acid Perfusion

Sucralfate in Duodenal Ulcer Disease: A Double-Blind Trial

1988 ◽  
Vol 8 (6) ◽  
pp. 443-447
Author(s):  
Mustafa M. Shennak ◽  
Tawfique M. Al-Sheikh ◽  
Mohammed T. Abu-Rajab
Keyword(s):  
Duodenal Ulcer ◽  
Double Blind Trial ◽  
Double Blind ◽  
Duodenal Ulcer Disease ◽  
Ulcer Disease ◽  
Blind Trial

Treatment of Duodenal Ulcer with Rioprostil: A Randomized Multicentre Double-Blind Study

1989 ◽  
Vol 24 (sup164) ◽  
pp. 191-193 ◽  
Author(s):  
T. Boucekkine ◽  
B. Meknini ◽  
A. Bitoun ◽  
F. Pruniéras ◽  
A. Khedis ◽  
...  
Keyword(s):  
Duodenal Ulcer ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind
Sign in / Sign up

Export Citation Format

Share Document